Company

ProQR Therapeutics NV

ProQR Therapeutics NV, based in Leiden, develops RNA-based therapies for genetic disorders using its Axiomer RNA editing technology.

About

Founded in 2012 in Leiden, Netherlands, by Daniel De Boer and Dinko Valerio, ProQR Therapeutics develops RNA therapies for genetic disorders using its proprietary Axiomer RNA editing technology. Daniel De Boer is CEO. The company has raised USD 97.5 mn through three funding rounds, most recently a VENTURE DEBT round of USD 30.00 mn from Pontifax Venture Capital on September 19, 2014. It recorded revenue of USD 7.05 mn in 2023.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in